Publication | Closed Access

Activity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial

Panzem® NcdMedicineGynecologyPlatinum-resistant Ovarian CancerCancer TreatmentOncologyRadiation OncologyGynecology OncologyEndocrine-related CancerOvarian CancerPrimary Peritoneal Carcinomatosis